SBC · Nasdaq, Nasdaq · CIK 0001930313
SBC Medical Group Holdings Inc
SBC Medical Group Holdings Inc’s most recent SEC filing in our snapshot is a Form 10-Q filed on Aug 13, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $173.6M and net income of $51.0M, according to its XBRL data on EDGAR. Its EDGAR record lists 3 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- SBC Medical Group Holdings Inc
- Tickers
- SBC, SBCWW
- SEC Central Index Key (CIK)
- 0001930313
- Industry (SIC)
- Services-Offices & Clinics of Doctors of Medicine (code 8011)
- Business address
- IRVINE, CA
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- SEC filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Position in SEC ticker list
- #2811 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from SBC Medical Group Holdings Inc’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|
| Revenue | $193.5M | $205.4M | $173.6M |
| Net income | $39.4M | $46.6M | $51.0M |
| Diluted EPS | $0.42 | $0.48 | $0.50 |
| Total assets | $258.8M | $266.1M | $380.4M |
| Cash and equivalents | $103.0M | $125.0M | $163.8M |
XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Mar 27, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Aug 13, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 13, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Aug 13, 2026 | Document · Index |
| May 28, 2026 | DEF 14A | Definitive proxy statement· period May 28, 2026 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about SBC Medical Group Holdings Inc, by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Aug 13, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 13, 2026 | 8-K | Results of operations; Regulation FD disclosure· period Aug 13, 2026 | Document · Index |
| Jul 14, 2026 | 8-K | Delisting notice; Change to shareholder rights; Charter, bylaws or fiscal year change; Shareholder vote results· period Jul 8, 2026 | Document · Index |
| May 28, 2026 | ARS | ARS· period Dec 31, 2025 | Document · Index |
| May 28, 2026 | DEFA14A | Additional proxy soliciting materials | Document · Index |
| May 28, 2026 | DEF 14A | Definitive proxy statement· period May 28, 2026 | Document · Index |
| May 20, 2026 | 8-K | Director or officer change· period May 14, 2026 | Document · Index |
| May 15, 2026 | PRE 14A | PRE 14A· period May 15, 2026 | Document · Index |
| May 14, 2026 | 10-Q | Quarterly report· period Mar 31, 2026 | Document · Index |
| May 14, 2026 | 8-K | Results of operations; Regulation FD disclosure· period May 14, 2026 | Document · Index |
| Apr 30, 2026 | 10-K/A | Amended annual report· period Dec 31, 2025 | Document · Index |
| Apr 29, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 28, 2026 | Document · Index |
| Apr 23, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Apr 21, 2026 | Document · Index |
| Apr 23, 2026 | 8-K | Material agreement· period Apr 19, 2026 | Document · Index |
| Apr 21, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Apr 20, 2026 | 424B7 | 424B7 | Document · Index |
| Apr 17, 2026 | 424B7 | 424B7 | Document · Index |
| Mar 27, 2026 | 8-K | Results of operations; Regulation FD disclosure; Other events· period Mar 27, 2026 | Document · Index |
| Mar 27, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Mar 13, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Mar 10, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Mar 6, 2026 | Document · Index |
| Mar 10, 2026 | SCHEDULE 13D/A | Active beneficial ownership report (over 5%) | Document · Index |
| Jan 5, 2026 | 424B3 | 424B3 | Document · Index |
| Jan 5, 2026 | 8-K | Regulation FD disclosure; Other events· period Jan 5, 2026 | Document · Index |
| Dec 31, 2025 | 8-K | Regulation FD disclosure; Other events· period Dec 31, 2025 | Document · Index |
| Dec 30, 2025 | EFFECT | EFFECT | Document · Index |
| Dec 29, 2025 | CORRESP | CORRESP | Document · Index |
| Dec 29, 2025 | S-3 | Simplified registration statement | Document · Index |
| Dec 15, 2025 | 8-K | Other events· period Dec 13, 2025 | Document · Index |
| Nov 17, 2025 | 424B3 | 424B3 | Document · Index |
| Nov 14, 2025 | DRS | DRS | Document · Index |
| Nov 14, 2025 | 10-Q | Quarterly report· period Sep 30, 2025 | Document · Index |
| Nov 14, 2025 | 8-K | Results of operations· period Nov 14, 2025 | Document · Index |
| Nov 13, 2025 | 8-K | Other events· period Nov 13, 2025 | Document · Index |
| Aug 15, 2025 | 424B3 | 424B3 | Document · Index |
| Aug 13, 2025 | 10-Q | Quarterly report· period Jun 30, 2025 | Document · Index |
| Aug 13, 2025 | 8-K | Results of operations· period Aug 13, 2025 | Document · Index |
| Aug 6, 2025 | 424B3 | 424B3 | Document · Index |
| Aug 4, 2025 | EFFECT | EFFECT | Document · Index |
| Jul 22, 2025 | POS AM | POS AM | Document · Index |
Insider filing activity
3 Form 4 filings appear in SBC Medical Group Holdings Inc’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Services-Offices & Clinics of Doctors of Medicine
All 4 companies in Services-Offices & Clinics of Doctors of Medicine· Companies headquartered in California
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001930313 and XBRL company facts. SBC Medical Group Holdings Inc on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement